/Investor DB

6 Dimensions Capital — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Frontera Therapeuticsfronteratherapeutics.cominSeries B · Jun 2022 · $160M

Frontera Therapeutics is a biotechnology company engaged in therapeutic research and development, spanning translational medicine, clinical operations, and manufacturing.

BiotechDeep TechHealthtechBoston, US

Xinyan Li(CEO)

Co-investorsOrbiMedBoyu CapitalCreacion VenturesHongShan Capital Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.